Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
The majority of adult patients affected by B-cell acute lymphoblastic leukemia (B-ALL) will relapse after an initial response, while approximately 20% will display primary resistant disease. Patients suffering from relapsed/refractory B-ALL have a very poor outcome. Allogeneic hematopoietic cell tra...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAABRON PRESS
2019-05-01
|
| シリーズ: | Clinical Hematology International |
| 主題: | |
| オンライン･アクセス: | https://www.atlantis-press.com/article/125907080/view |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|